首页|美托洛尔片联合曲美他嗪片治疗稳定型心绞痛患者的效果

美托洛尔片联合曲美他嗪片治疗稳定型心绞痛患者的效果

扫码查看
目的 分析稳定型心绞痛(SAP)患者采取美托洛尔片+曲美他嗪片治疗的效果。方法 86例SAP患者,随机分为观察组和对照组,每组 43 例。对照组采用常规治疗,观察组采用美托洛尔片+曲美他嗪片治疗。比较两组患者西雅图心绞痛问卷(SAQ)评分(疾病认知度、心绞痛稳定状态、心绞痛发作、活动受限度评分)以及治疗前后心绞痛发作情况、生活质量评分(总体健康、精力、社会功能、心理健康、躯体疼痛、躯体角色功能、情绪角色功能、躯体健康评分)、心肌营养素-1(CT-1)水平、血清活氧物质(ROS)水平。结果 治疗后,观察组患者心绞痛发作次数(1。55±0。44)次/周少于对照组的(3。08±0。55)次/周,发作时间(1。68±1。18)min/次短于对照组的(3。48±1。48)min/次(P<0。05)。观察组患者疾病认知度评分(16。55±1。97)分、心绞痛稳定状态评分(15。35±1。76)分、心绞痛发作评分(19。06±2。12)分、活动受限度评分(58。17±6。50)分均高于对照组的(12。41±1。57)、(10。68±1。23)、(14。17±1。83)、(49。75±5。66)分(P<0。05)。治疗后,观察组患者总体健康评分(63。26±4。49)分、精力评分(74。26±4。55)分、社会功能评分(83。66±3。92)分、心理健康评分(81。49±4。26)分、躯体疼痛评分(74。49±6。39)分、躯体角色功能评分(73。53±4。19)分、情绪角色功能评分(84。53±3。68)分、躯体健康评分(71。38±4。29)分均高于对照组的(54。55±3。26)、(61。23±4。02)、(76。33±2。76)、(61。25±3。76)、(66。59±4。71)、(61。23±4。43)、(73。06±2。51)、(52。30±2。77)分(P<0。05)。治疗后,观察组患者CT-1(42。51±4。95)pg/L、ROS(550。01±56。96)U/ml均低于对照组的(55。01±6。06)pg/L、ROS(645。75±66。01)U/ml(P<0。05)。结论 SAP患者选取美托洛尔片联合曲美他嗪片治疗存在显著的治疗效果,可有效改善患者的CT-1、ROS水平,同时减少心绞痛发作次数,缩短了发作的时间,让患者疾病认知度、心绞痛稳定状态以及生活质量有所提高,安全性较高,值得推广应用。
Effect of metoprolol tablets combined with trimetazidine tablets on patients with stable angina pectoris
Objective To analyze the effect of metoprolol tablets combined with trimetazidine tablets on patients with stable angina pectoris(SAP).Methods 86 patients with SAP were randomly divided into the observation group and the control group,with 43 cases in each group.The control group was given conventional treatment,while the observation group was given metoprolol tablet + trimetazidine tablets.Comparison was made on Seattle Angina Questionnaire(SAQ)scores(disease awareness,angina stable state,angina attacks,activity limits scores),angina attacks before and after treatment,quality of life scores(general health,energy,social functioning,mental health,physical pain,somatic role functioning,emotional role functioning,physical health scores),and cardiotrophin-1(CT-1)and reactive oxygen species(ROS)between the two groups.Results After treatment,the frequency of angina attacks in the observation group was(1.55±0.44)times per week,which was less than that of(3.08±0.55)times per week in the control group,and the duration of angina attacks was(1.68±1.18)min/time,which was shorter than that of(3.48±1.48)min/time in the control group(P<0.05).In the observation group,the disease awareness score was(16.55±1.97)points,the angina stable state score was(15.35±1.76)points,the angina attack score was(19.06±2.12)points and the activity limit score was(58.17±6.50)points,which were higher than those of(12.41±1.57),(10.68±1.23),(14.17±1.83)and(49.75±5.66)points in the control group(P<0.05).After treatment,in the observation group,the overall health score was(63.26±4.49)points,the energy score was(74.26±4.55)points,the social function score was(83.66±3.92)points,the mental health score was(81.49±4.26)points,the somatic pain score was(74.49±6.39)points,and the somatic role functioning score was(73.53±4.19)points,the emotional role functioning score was(84.53±3.68)points and the somatic health score was(71.38±4.29)points,which were higher than those of(54.55±3.26),(61.23±4.02),(76.33±2.76),(61.25±3.76),(66.59±4.71),(61.23±4.43),(73.06±2.51)and(52.30±2.77)points in the control group(P<0.05).After treatment,CT-1 of(42.51±4.95)pg/L and ROS of(550.01±56.96)U/ml in the observation groups were lower than those of(55.01±6.06)pg/L and(645.75±66.01)U/ml in the control group(P<0.05).Conclusion The combination of metoprolol tablets and trimetazidine tablets has significant therapeutic effects in the treatment of SAP,which can effectively improve the level of CT-1 and ROS of patients,reduce the frequency of angina attacks,shorten the duration of angina attacks,and improve the disease awareness,stable state of angina and quality of life of patients,which is safe and worthy of promotion and application.

Stable angina pectorisMetoprolol tabletsRoutine treatmentNumber of seizuresTrimetazidine tablets

张晶晶

展开 >

024000 内蒙古自治区赤峰市医院药剂科

稳定型心绞痛 美托洛尔片 常规治疗 发作次数 曲美他嗪片

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(1)
  • 20